CONSORT 2010 Statement - Unfinished update?

Journal of Clinical Epidemiology

Volumn 64, Issue 6, 2011, Pages 579-582

  Cals, Jochen W L ^a,b   Van Amelsvoort, Ludovic G P M ^a   Kotz, Daniel ^a   Spigt, Mark G ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; CLUSTER ANALYSIS; CONSOLIDATED STANDARDS OF REPORTING TRIALS; HERBAL MEDICINE; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; PHARMACOEPIDEMIOLOGY; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955045959     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2010.10.007     Document Type: Note

References (23)

1. D.G. Altman Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors BMJ 330 2005 1056 1057 (Pubitemid 40646557)
2. S. Hopewell, D.G. Altman, D. Moher, and K.F. Schulz Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' Trials 9 2008 20
3. A.C. Plint, D. Moher, A. Morrison, K. Schulz, D.G. Altman, and C. Hill Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review Med J Aust 185 2006 263 267 (Pubitemid 44382877)
4. R.L. Kane, J. Wang, and J. Garrard Reporting in randomized clinical trials improved after adoption of the CONSORT statement J Clin Epidemiol 60 2007 241 249 (Pubitemid 46210137)
5. D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, and D. Elbourne The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Intern Med 134 2001 663 694 (Pubitemid 32322245)
6. S. Hopewell, S. Dutton, L.M. Yu, A.W. Chan, and D.G. Altman The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed BMJ 340 2010 c723
7. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c332
8. D. Moher, S. Hopewell, K.F. Schulz, V. Montori, P.C. Gotzsche, and P.J. Devereaux CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials J Clin Epidemiol 63 2010 e1 e37
9. M.J. Campbell Extending CONSORT to include cluster trials BMJ 328 2004 654 655 (Pubitemid 38393398)
10. J.P. Ioannidis, S.J. Evans, P.C. Gotzsche, R.T. O'Neill, D.G. Altman, and K. Schulz Better reporting of harms in randomized trials: an extension of the CONSORT statement Ann Intern Med 141 2004 781 788 (Pubitemid 39524916)
11. J.J. Gagnier, H. Boon, P. Rochon, D. Moher, J. Barnes, and C. Bombardier Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration J Clin Epidemiol 59 2006 1134 1149 (Pubitemid 44485435)
12. G. Piaggio, D.R. Elbourne, D.G. Altman, S.J. Pocock, and S.J. Evans Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement JAMA 295 2006 1152 1160 (Pubitemid 43352345)
13. I. Boutron, D. Moher, D.G. Altman, K.F. Schulz, and P. Ravaud Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration Ann Intern Med 148 2008 295 309 (Pubitemid 351665487)
14. S. Hopewell, M. Clarke, D. Moher, E. Wager, P. Middleton, and D.G. Altman CONSORT for reporting randomised trials in journal and conference abstracts Lancet 371 2008 281 283
15. M. Zwarenstein, S. Treweek, J.J. Gagnier, D.G. Altman, S. Tunis, and B. Haynes Improving the reporting of pragmatic trials: an extension of the CONSORT statement BMJ 337 2008 a2390
16. K.J. Lee, and S.G. Thompson Clustering by health professional in individually randomised trials BMJ 330 2005 142 144 (Pubitemid 40138505)
17. K.J. Lee, and S.G. Thompson The use of random effects models to allow for clustering in individually randomized trials Clin Trials 2 2005 163 173 (Pubitemid 40637899)
18. A.R. Localio, J.A. Berlin, T.R. Ten Have, and S.E. Kimmel Adjustments for center in multicenter studies: an overview Ann Intern Med 135 2001 112 123 (Pubitemid 32661194)
19. K.E. Thorpe, M. Zwarenstein, A.D. Oxman, S. Treweek, C.D. Furberg, and D.G. Altman A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers J Clin Epidemiol 62 2009 464 475
20. H. Bang, L. Ni, and C.E. Davis Assessment of blinding in clinical trials Control Clin Trials 25 2004 143 156 (Pubitemid 38328755)
21. R.A. Schnoll, L. Epstein, J. Audrain, R. Niaura, L. Hawk, and P.G. Shields Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation J Subst Abuse Treat 34 2008 234 241 (Pubitemid 351187801)
22. M.E. Falagas, T. Grigori, and E. Ioannidou A systematic review of trends in the methodological quality of randomized controlled trials in various research fields J Clin Epidemiol 62 2009 227 231 e1-9
23. D. Moher, I. Simera, K.F. Schulz, J. Hoey, and D.G. Altman Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research BMC Med 6 2008 13